GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyorin Pharmaceutical Co Ltd (TSE:4569) » Definitions » Sale Of Business

Kyorin Pharmaceutical Co (TSE:4569) Sale Of Business : 円0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kyorin Pharmaceutical Co Sale Of Business?

Kyorin Pharmaceutical Co's sale of business for the three months ended in Jun. 2024 was 円0 Mil. It means Kyorin Pharmaceutical Co gained 円0 Mil from selling business. Kyorin Pharmaceutical Co's sale of business for the trailing twelve months (TTM) ended in Jun. 2024 was 円0 Mil.

Compared with last quarter (円0 Mil in Mar. 2024 ), Kyorin Pharmaceutical Co gained the same money from selling business in Jun. 2024 (円0 Mil).


Kyorin Pharmaceutical Co Sale Of Business Historical Data

The historical data trend for Kyorin Pharmaceutical Co's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyorin Pharmaceutical Co Sale Of Business Chart

Kyorin Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 921.00

Kyorin Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kyorin Pharmaceutical Co Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kyorin Pharmaceutical Co Sale Of Business Related Terms

Thank you for viewing the detailed overview of Kyorin Pharmaceutical Co's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyorin Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311
Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Kyorin Pharmaceutical Co Headlines

No Headlines